Correspondence 0001193125-23-242064 from VACCINEX, INC. (VCNX) (CIK 0001205922) (VCNX)
VACCINEX, INC. (VCNX) (CIK 0001205922)
Date: Sept. 26, 2023 · CIK: 0001205922 · Accession: 0001193125-23-242064
AI Filing Summary & Sentiment
File numbers found in text: 333-274520
Letter
Vaccinex, Inc.
1895 Mount Hope Avenue
Rochester, New York 14620
September 26, 2023
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Vaccinex, Inc.
Registration Statement on Form S-1
File No. 333-274520
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Vaccinex, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1, as amended (the “Registration Statement”), and declare the Registration Statement effective as of 4:05 p.m., Eastern Time, on September 26, 2023, or as soon thereafter as is practicable, or at such other time as the Company may orally request by telephone. The Company hereby authorizes William Intner and Nick Hoover of Hogan Lovells US LLP, counsel to the Company, to make such request on its behalf.
Please feel free to direct any questions or comments concerning this request to Mr. Intner at (410) 659-2778, and once the Registration Statement has been declared effective, please notify Mr. Intner by calling him at the same phone number.
Very truly yours,
Vaccinex, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Vaccinex, Inc. 1895 Mount Hope Avenue Rochester, New York 14620 September 26, 2023 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Vaccinex, Inc. Registration Statement on Form S-1 File No. 333-274520 Request for Acceleration of Effectiveness Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Vaccinex, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1, as amended (the “Registration Statement”), and declare the Registration Statement effective as of 4:05 p.m., Eastern Time, on September 26, 2023, or as soon thereafter as is practicable, or at such other time as the Company may orally request by telephone. The Company hereby authorizes William Intner and Nick Hoover of Hogan Lovells US LLP, counsel to the Company, to make such request on its behalf. Please feel free to direct any questions or comments concerning this request to Mr. Intner at (410) 659-2778, and once the Registration Statement has been declared effective, please notify Mr. Intner by calling him at the same phone number. Very truly yours, Vaccinex, Inc. /s/ Scott E. Royer By: Scott E. Royer Title: Chief Financial Officer